About Alpine Immune Sciences
Alpine Immune Sciences is a company based in Seattle (United States) founded in 2015 was acquired by Vertex Pharmaceuticals in April 2024.. Alpine Immune Sciences has raised $49.25 million across 5 funding rounds from investors including Vertex Pharmaceuticals, Orbimed and Frazier Healthcare Partners. The company has 126 employees as of December 31, 2022. Alpine Immune Sciences has completed 1 acquisition, including Nivalis. Alpine Immune Sciences operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Seattle, United States
- Employees 126 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$58.88 M96as on Dec 31, 2023
-
Net Profit
$-32.18 M44as on Dec 31, 2023
-
EBITDA
$-44.25 M24as on Dec 31, 2023
-
Total Equity Funding
$49.25 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Vertex Pharmaceuticals
& 11 more
-
Employee Count
126
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Vertex Pharmaceuticals
(Apr 10, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Alpine Immune Sciences
Alpine Immune Sciences has successfully raised a total of $49.25M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(12 May 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Post-IPO - Alpine Immune Sciences | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Alpine Immune Sciences | Valuation |
investors |
|
| Jan, 2019 | Amount | Post-IPO - Alpine Immune Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alpine Immune Sciences
Alpine Immune Sciences has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Vertex Pharmaceuticals, Orbimed and Frazier Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science and technology sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alpine Immune Sciences
Alpine Immune Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nivalis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for cystic fibrosis are developed.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Alpine Immune Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alpine Immune Sciences Comparisons
Competitors of Alpine Immune Sciences
Alpine Immune Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alpine Immune Sciences
Frequently Asked Questions about Alpine Immune Sciences
When was Alpine Immune Sciences founded?
Alpine Immune Sciences was founded in 2015.
Where is Alpine Immune Sciences located?
Alpine Immune Sciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Alpine Immune Sciences a funded company?
Alpine Immune Sciences is a funded company, having raised a total of $49.25M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $25.27M, raised on May 12, 2015.
How many employees does Alpine Immune Sciences have?
As of Dec 31, 2022, the latest employee count at Alpine Immune Sciences is 126.
What is the annual revenue of Alpine Immune Sciences?
Annual revenue of Alpine Immune Sciences is $58.88M as on Dec 31, 2023.
What does Alpine Immune Sciences do?
Developer of immunotherapies to treat cancer and autoimmune disorders. The company focused on discovering and developing innovative, protein-based immunotherapies which include Acazicolcept (ALPN-101) and Povetacicept (ALPN-303), which are dual costimulation antagonists for autoimmune diseases.
Who are the top competitors of Alpine Immune Sciences?
Alpine Immune Sciences's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
How many acquisitions has Alpine Immune Sciences made?
Alpine Immune Sciences has made 1 acquisition, including Nivalis.
Who are Alpine Immune Sciences's investors?
Alpine Immune Sciences has 12 investors. Key investors include Vertex Pharmaceuticals, Orbimed, Frazier Healthcare Partners, Decheng Capital, and TCG Crossover.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.